SCHEMBL22744378

SCHEMBL22744378

c1ccc2nc3c(cc2c1)CNCCO3

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30588965 1.00 MAPT (0.38) MAPTALDH1A1GLAHPGDACHE
SCHEMBL22744288 0.81 MEN1 (0.37) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL29120937 0.78 ALDH1A1 (0.46) MAPTALDH1A1GLAHPGDACHE
SCHEMBL22744576 0.77 SSTR4 (0.41) ALDH1A1KDM4ETSHRSSTR4SSTR1
SCHEMBL22743879 0.76 ALDH1A1 (0.39) MAPTALDH1A1GLAHPGDACHE
SCHEMBL29120932 0.76 GRM1 (0.55) MAPTALDH1A1GLAHPGDACHE
SCHEMBL30632987 0.76 GRM1 (0.55) MAPTALDH1A1GLAHPGDACHE
SCHEMBL22744552 0.73 OXTR (0.39) ACHESSTR4PNMTCD44MAOB
SCHEMBL30751773 0.72 CYP3A4 (0.55) MAPTALDH1A1GLAHPGDACHE
SCHEMBL2401358 0.72 CYP3A4 (0.55) MAPTALDH1A1GLAHPGDACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF Genetic Intelligence, Inc 2023-08-31 — — US disclosed
WO-2020241853-A1 BENZOTRIAZOLE DERIVATIVE 宇部興産株式会社 2020-12-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF TARDBP, FUS, RBM17 MAPT 343/4885ALDH1A1 4065/4885GLA 2335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback